Hein Than
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 24
- Chronic Myeloid Leukemia Treatments 16
- Acute Myeloid Leukemia Research 10
- Hematopoietic Stem Cell Transplantation 6
- Genetics 10
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Charles T. H. Chuah (8 shared papers)Wei Xiang (3 shared papers)Anthony D. Pomicter (3 shared papers)Thomas O’Hare (2 shared papers)Dongqing Yan (3 shared papers)Michael W. Deininger (3 shared papers)Jamshid Sorouri Khorashad (2 shared papers)Jit Kong Cheong (1 shared paper)
- Journals
- Blood (7 papers)Leukemia (3 papers)Hematological Oncology (3 papers)Bone Marrow Transplantation (1 paper)Nature Medicine (1 paper)
- Partner nations
- SingaporeUnited StatesUnited Kingdom
In The Last Decade
Hein Than
31 papers receiving 978 citations
Hein Than's Hit Papers
Peers
Comparison fields: 5 of 68
- Hematology 348
- Genetics 213
- Geriatrics and Gerontology 33
- Oncology 228
- Pulmonary and Respiratory Medicine 233
Countries citing papers authored by Hein Than
This map shows the geographic impact of Hein Than's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hein Than with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hein Than more than expected).
Fields of papers citing papers by Hein Than
This network shows the impact of papers produced by Hein Than. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hein Than. The network helps show where Hein Than may publish in the future.
Co-authors
The 25 scholars most cited alongside Hein Than, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer Hit paper breakdown → | 2012 | 494 |
| 2 | 2019 | 184 | |
| 3 | 2021 | 54 | |
| 4 | 2015 | 45 | |
| 5 | 2019 | 37 | |
| 6 | 2018 | 32 | |
| 7 | 2020 | 22 | |
| 8 | 2023 | 21 | |
| 9 | 2019 | 19 | |
| 10 | 2016 | 17 | |
| 11 | 2023 | 10 | |
| 12 | 2012 | 7 | |
| 13 | 2018 | 6 | |
| 14 | 2015 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2018 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2016 | 2 |
About Hein Than
Hein Than is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Immunology, having authored 37 papers that have together received 992 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (16 papers), Acute Myeloid Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), CAR-T cell therapy research (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Ocular Surface and Contact Lens (2 papers). The work is most often cited by research in Hematology (348 citations), Genetics (213 citations), Geriatrics and Gerontology (33 citations), Oncology (228 citations) and Pulmonary and Respiratory Medicine (233 citations). Hein Than has collaborated with scholars based in Singapore, United States and United Kingdom. Frequent co-authors include Charles T. H. Chuah, Wei Xiang, Anthony D. Pomicter, Thomas O’Hare, Dongqing Yan, Michael W. Deininger, Jamshid Sorouri Khorashad, Jit Kong Cheong, Peng Xu and Ralph Milford Bunte. Their work appears in journals such as Blood, Leukemia, Hematological Oncology, Bone Marrow Transplantation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.